We are live on
!
Find out more
WF
Welch & Forbes Portfolio holdings
AUM
$8.23B
1-Year Est. Return
17.62%
This Fund
S&P 500
This Quarter
Est. Return
-1.2%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.88B
AUM Growth
+$134M
(+3.6%)
Cap. Flow
+$219M
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
22.53%
Holding
368
New
30
Increased
108
Reduced
154
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$51M |
| 2 |
Chubb
CB
|
+$44M |
| 3 |
Abbott
ABT
|
+$37.6M |
| 4 |
Aflac
AFL
|
+$31M |
| 5 |
AT&T
T
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EACQ
Easterly Acquisition Corp
EACQ
|
+$10M |
| 2 |
CVS Health
CVS
|
+$6.32M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$4.84M |
| 4 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$4.74M |
| 5 |
ExxonMobil
XOM
|
+$4.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.2% |
| 2 | Technology | 17.48% |
| 3 | Financials | 12.88% |
| 4 | Industrials | 9.97% |
| 5 | Consumer Discretionary | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Novartis
NVS
$301B
| $9.02M | 0.23% |
124,480
+1,372
| +1% | +$104K |
|
102
Valero Energy
VLO
$92.6B
| $8.98M | 0.23% |
96,853
+92,088
| +1,933% | +$8.6M |
|
103
Hain Celestial
HAIN
$44.4M
| $8.97M | 0.23% |
279,648
+1,358
| +0.5% | +$49.3K |
|
104
Constellation Brands
STZ
$22.3B
| $8.95M | 0.23% |
39,267
+35,388
| +912% | +$7.79M |
|
105
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $8.81M | 0.23% |
33,478
-2,990
| -8% | -$816K |
|
106
Air Products & Chemicals
APD
$66.8B
| $8.46M | 0.22% |
53,173
+24
| +0% | +$3.96K |
|
107
United Parcel Service
UPS
$89.5B
| $8.21M | 0.21% |
78,400
-295
| -0.4% | -$34.1K |
|
108
Duke Energy
DUK
$98.4B
| $8.18M | 0.21% |
105,598
+9,574
| +10% | +$740K |
|
|
CVGW
109
DELISTED
Calavo Growers
CVGW
| $8.1M | 0.21% |
87,841
+7,405
| +9% | +$648K |
|
110
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $8.04M | 0.21% |
98,384
-8,575
| -8% | -$704K |
|
111
Colgate-Palmolive
CL
$73.3B
| $7.58M | 0.2% |
105,764
+5,476
| +5% | +$394K |
|
112
Walt Disney
DIS
$167B
| $7.55M | 0.19% |
75,158
+4,131
| +6% | +$439K |
|
113
Cintas
CTAS
$82.7B
| $7.27M | 0.19% |
170,480
-20,428
| -11% | -$848K |
|
114
Oracle
ORCL
$367B
| $7.26M | 0.19% |
158,724
-7,199
| -4% | -$358K |
|
115
Invesco Senior Loan ETF
BKLN
$6.97B
| $6.98M | 0.18% |
301,725
-8,790
| -3% | -$203K |
|
116
EOG Resources
EOG
$77.5B
| $6.95M | 0.18% |
66,030
+7,263
| +12% | +$783K |
|
117
Amgen
AMGN
$209B
| $6.82M | 0.18% |
40,028
-1,362
| -3% | -$250K |
|
|
TIF
118
DELISTED
Tiffany & Co.
TIF
| $6.8M | 0.18% |
69,671
+1,295
| +2% | +$134K |
|
119
ConocoPhillips
COP
$145B
| $6.72M | 0.17% |
113,366
+5,430
| +5% | +$307K |
|
120
Vanguard FTSE Europe ETF
VGK
$30.8B
| $6.72M | 0.17% |
115,508
+77,913
| +207% | +$4.67M |
|
121
American Express
AXP
$228B
| $6.46M | 0.17% |
69,279
+3,075
| +5% | +$298K |
|
122
Caterpillar
CAT
$373B
| $6.2M | 0.16% |
42,069
-9,210
| -18% | -$1.45M |
|
123
DuPont de Nemours
DD
$18.7B
| $6.18M | 0.16% |
38,313
-912
| -2% | -$165K |
|
|
SRCL
124
DELISTED
Stericycle Inc
SRCL
| $5.93M | 0.15% |
101,259
-71,446
| -41% | -$4.84M |
|
|
WBA
125
DELISTED
Walgreens Boots Alliance
WBA
| $5.92M | 0.15% |
90,350
+1,285
| +1% | +$91.8K |
|
Similar funds
OC
LGF
CCM
CL
WJWM
WA
GGHC
CCM
Welch & Forbes's Q1 2018 Portfolio in Review
As of Q1 2018, Welch & Forbes held 368 positions worth $3.88B, up 3.6% from $3.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Welch & Forbes deployed $219M of net new capital in Q1 2018, opening 30 new positions and adding to 108 existing holdings. Its largest new stake was AbbVie: 464,710 shares worth $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $6.32M trimmed.
- Welch & Forbes's largest Q1 2018 buy was AbbVie: 464,710 shares worth $44M.
- Welch & Forbes added most to Johnson & Johnson in Q1 2018, an estimated $8.9M increase.
- Welch & Forbes's biggest Q1 2018 reduction was CVS Health, cutting an estimated $6.32M.
- Welch & Forbes fully exited Easterly Acquisition Corp in Q1 2018, selling an estimated $10M.
- Welch & Forbes's ten largest holdings make up 23% of its $3.88B portfolio in Q1 2018.
- Welch & Forbes opened 30 new positions and closed 12 in Q1 2018.
- Welch & Forbes's portfolio value rose 3.6% quarter-over-quarter to $3.88B.
Based on Welch & Forbes's 13F filing for Q1 2018, filed 12 Apr 2018.